Evidence V2 · Full R&D Dataset
Scaled peptide evidence,
structured for decisions.
Evidence V1 preserves the 126-study MSc dissertation benchmark. Evidence V2 is the scaled operational dataset: 94,826 papers discovered and 6,240 structured studies in the current public snapshot.
50 peptide entitiesstudy-level drill-downlocal LLM extractionseparate efficacy & quality metrics
6,240Structured studiesCurrent Evidence V2 snapshot
3,579Randomised trials57.4% of extracted evidence
5,900Human evidence94.6% of extracted evidence
50Peptide entities32,437 A+B deep candidates
Evidence landscape
What the scaled dataset contains.
Compact dashboard views of the current Evidence V2 snapshot.
Deep evidence by peptide
Top 10 entities by successfully extracted study count.
Study-design mix
The current extracted set is strongly human and trial-led.
6,240records
Randomised trials3,579
Other human clinical2,101
Animal204
Observational human152
In vitro120
Other / secondary84
Publication activity over time
Extracted studies published from 2000 onward.
Outcome direction
Direction is kept separate from evidence quality.
Positive
4,355
Mixed
827
Negative
658
No effect
190
Unclear
210
A positive study result is not automatically strong evidence. Evidence V2 tracks result direction, methodological quality and translation separately.
Peptide explorer
Compare evidence profiles.
Study-level evidence
Interrogate Evidence V2.
| Study | Peptide | Design | Direction | Evidence | Translation | Year |
|---|
Dataset distinction
V1 is the academic benchmark. V2 is the scaled research engine.
Evidence V1
Dissertation dataset
Frozen 126-study dataset used to validate the MSc methodology.
Evidence V2
Full R&D dataset
Scaled operational evidence layer that expands as later evidence tiers are processed.